From Bedside to Bench: the Role of Anti-Tumor Necrosis Factor Agents in the Management of Immune-Mediated Inflammatory Diseases.
Haraoui
Boulos
B
Université de Montréal, CHUM, Hôpital Notre Dame, Montreal, Quebec, Canada. boulos.haraoui@ssss.gouv.qc.ca
Russell
Anthony S
AS
Keystone
Edward C
EC
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy* / Q000276:immunology; D018836:Inflammation Mediators / Q000037:antagonists & inhibitors* / Q000378:metabolism; D057170:Translational Research, Biomedical; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D018836:Inflammation Mediators; D014409:Tumor Necrosis Factor-alpha